Recursion Pharmaceuticals Inc vs Tapestry, Inc. — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Tapestry, Inc. trades at $161 (market cap $32.44B). The key difference: Tapestry, Inc. is far larger — about 17.9× Recursion Pharmaceuticals Inc's market cap, and Tapestry, Inc. pays a 1% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | TPR | |
|---|---|---|
Market Cap | $1.81B | $32.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $164.78 |
52-Week Low | $2.84 | $95.69 |
Enterprise Value | $1.33B | $35.29B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →